These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22525084)

  • 21. In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles.
    Liu Y; Di Zang H; Kong M; Ma FK; Dang QF; Cheng XJ; Ji QX; Chen XG
    Carbohydr Polym; 2012 Jun; 89(2):453-60. PubMed ID: 24750743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of intestinal barrier properties by miltefosine.
    Menez C; Buyse M; Chacun H; Farinotti R; Barratt G
    Biochem Pharmacol; 2006 Feb; 71(4):486-96. PubMed ID: 16337152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion.
    Gagnon M; Zihler Berner A; Chervet N; Chassard C; Lacroix C
    J Microbiol Methods; 2013 Sep; 94(3):274-9. PubMed ID: 23835135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption.
    Smith JM; Dornish M; Wood EJ
    Biomaterials; 2005 Jun; 26(16):3269-76. PubMed ID: 15603822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption.
    Mo R; Xiao Y; Sun M; Zhang C; Ping Q
    Int J Pharm; 2011 May; 409(1-2):38-45. PubMed ID: 21356302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans.
    Heinen C; Reuss S; Saaler-Reinhardt S; Langguth P
    Eur J Pharm Biopharm; 2013 Sep; 85(1):26-33. PubMed ID: 23958316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer.
    Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA
    Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
    Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
    Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of nicotine in vitro on the integrity of tight junctions in Caco-2 cell monolayers.
    McGilligan VE; Wallace JM; Heavey PM; Ridley DL; Rowland IR
    Food Chem Toxicol; 2007 Sep; 45(9):1593-8. PubMed ID: 17399881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cadmium chloride on the paracellular barrier function of intestinal epithelial cell lines.
    Duizer E; Gilde AJ; Versantvoort CH; Groten JP
    Toxicol Appl Pharmacol; 1999 Mar; 155(2):117-26. PubMed ID: 10053166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
    Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
    Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring Effects of Chitosan Oligosaccharides on the DSS-Induced Intestinal Barrier Impairment In Vitro and In Vivo.
    Wang Y; Wen R; Liu D; Zhang C; Wang ZA; Du Y
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33920375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of tight junction modulating lipids.
    Chen-Quay SC; Eiting KT; Li AW; Lamharzi N; Quay SC
    J Pharm Sci; 2009 Feb; 98(2):606-19. PubMed ID: 18563833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
    Schipper NG; Vârum KM; Stenberg P; Ocklind G; Lennernäs H; Artursson P
    Eur J Pharm Sci; 1999 Aug; 8(4):335-43. PubMed ID: 10425384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transport of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells.
    Salomon JJ; Endter S; Tachon G; Falson F; Buckley ST; Ehrhardt C
    Eur J Pharm Biopharm; 2012 Jun; 81(2):351-9. PubMed ID: 22426135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhamnolipids as epithelial permeability enhancers for macromolecular therapeutics.
    Perinelli DR; Vllasaliu D; Bonacucina G; Come B; Pucciarelli S; Ricciutelli M; Cespi M; Itri R; Spinozzi F; Palmieri GF; Casettari L
    Eur J Pharm Biopharm; 2017 Oct; 119():419-425. PubMed ID: 28743594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening.
    Yeh TH; Hsu LW; Tseng MT; Lee PL; Sonjae K; Ho YC; Sung HW
    Biomaterials; 2011 Sep; 32(26):6164-73. PubMed ID: 21641031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of berberine in vitro on tight junctions in human Caco-2 intestinal epithelial cells.
    Gu L; Li N; Li Q; Zhang Q; Wang C; Zhu W; Li J
    Fitoterapia; 2009 Jun; 80(4):241-8. PubMed ID: 19243699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption.
    Boegh M; Baldursdóttir SG; Müllertz A; Nielsen HM
    Eur J Pharm Biopharm; 2014 Jul; 87(2):227-35. PubMed ID: 24413146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
    van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
    Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.